Michelle Casey
Royal College of Surgeons in Ireland(IE)Beaumont Hospital(IE)Botsford Hospital(US)Beaumont Hospital, Dearborn(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Cystic Fibrosis Research Advances, Melanoma and MAPK Pathways
Most-Cited Works
- → Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma(2012)2,130 cited
- → Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma(2014)1,843 cited
- → Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group(2012)1,342 cited
- → Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer(2010)958 cited
- → A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses(2008)802 cited
- → Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy(2016)765 cited